[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Thyroid Cancer Diagnostic Market Size study, by Type (Papillary carcinoma, Follicular carcinoma, Others), by Technique (Blood test, Imaging, Biopsy, Others), by End-Use (Hospital laboratories, Cancer diagnostic centers, Research institutes) and Regional Forecasts 2020-2027

September 2020 | 200 pages | ID: GB750611E1D2EN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Thyroid Cancer Diagnostic Market is valued approximately at USD 2.4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2020-2027. Thyroid cancer is a sort of cancer that usually arises when an unusual cell begins to grow up in the thyroid gland, liable for the secretion of thyroid hormones. This gland is typically found in the front of the neck. This cancer is extremely infrequent among the people. To precisely treat and diagnose thyroid cancer, healthcare professional generally reviews the entire medical history of a patient suffering from this cancer. However, this cancer might reoccur even after many years of the treatment, thus accurate diagnosis of thyroid cancer is required, which may contribute to the market growth around the world. Furthermore, the rise in the prevalence of thyroid cancer, along with the advancements & innovation in diagnosis technology are the few factors responsible for the CAGR of the market during the forecast period. For instance, as per the National Institute of Health (NIH), the rate of new cases of thyroid cancer is estimated at around 15.7 per 100,000 women and men each year. Also, the death rate estimated almost 0.5 per 100,000 women and men every year. Similarly, according to the American Cancer Society, about 52,890 new cases of thyroid cancer were estimated in 2020, of which nearly 41,170 in women and 12,720 in men. This, in turn, is expected to strengthen the need for thyroid cancer diagnostics, making a significant impact on the market growth all over the world. However, the high cost of diagnosis coupled with adverse effects of diagnosis are the few major factors inhibiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Thyroid Cancer Diagnostic market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the increasing awareness among individuals and reimbursement policies, and the large presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the growing prevalence of thyroid cancer along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the Thyroid Cancer Diagnostic market across the Asia-Pacific region.

Major market player included in this report are:
F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Thermo Fisher Scientific, Inc.
General Electric
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
Toshiba Corporation
Koninklijke Philips N.V.
Agilent Technologies, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Papillary carcinoma
Follicular carcinoma
Others

By Technique:
Blood test
Imaging
Biopsy
Others

By End-Use:
Hospital laboratories
Cancer diagnostic centers
Research institutes

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Thyroid Cancer Diagnostic Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
  1.2.1. Thyroid Cancer Diagnostic Market, by Region, 2018-2027 (USD Billion)
  1.2.2. Thyroid Cancer Diagnostic Market, by Type, 2018-2027 (USD Billion)
  1.2.3. Thyroid Cancer Diagnostic Market, by Technique, 2018-2027 (USD Billion)
  1.2.4. Thyroid Cancer Diagnostic Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL THYROID CANCER DIAGNOSTIC MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL THYROID CANCER DIAGNOSTIC MARKET DYNAMICS

3.1. Thyroid Cancer Diagnostic Market Impact Analysis (2018-2027)
  3.1.1. Market Drivers
  3.1.2. Market Challenges
  3.1.3. Market Opportunities

CHAPTER 4. GLOBAL THYROID CANCER DIAGNOSTIC MARKET: INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL THYROID CANCER DIAGNOSTIC MARKET, BY TYPE

5.1. Market Snapshot
5.2. Global Thyroid Cancer Diagnostic Market by Type, Performance - Potential Analysis
5.3. Global Thyroid Cancer Diagnostic Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Thyroid Cancer Diagnostic Market, Sub Segment Analysis
  5.4.1. Papillary carcinoma
  5.4.2. Follicular carcinoma
  5.4.3. Others

CHAPTER 6. GLOBAL THYROID CANCER DIAGNOSTIC MARKET, BY TECHNIQUE

6.1. Market Snapshot
6.2. Global Thyroid Cancer Diagnostic Market by Technique, Performance - Potential Analysis
6.3. Global Thyroid Cancer Diagnostic Market Estimates & Forecasts by Technique 2017-2027 (USD Billion)
6.4. Thyroid Cancer Diagnostic Market, Sub Segment Analysis
  6.4.1. Blood test
  6.4.2. Imaging
  6.4.3. Biopsy
  6.4.4. Others

CHAPTER 7. GLOBAL THYROID CANCER DIAGNOSTIC MARKET, BY END-USE

7.1. Market Snapshot
7.2. Global Thyroid Cancer Diagnostic Market by End-Use - Potential Analysis
7.3. Global Thyroid Cancer Diagnostic Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
7.4. Thyroid Cancer Diagnostic Market, Sub Segment Analysis
  7.4.1. Hospital laboratories
  7.4.2. Cancer diagnostic centers
  7.4.3. Research institutes

CHAPTER 8. GLOBAL THYROID CANCER DIAGNOSTIC MARKET, REGIONAL ANALYSIS

8.1. Thyroid Cancer Diagnostic Market, Regional Market Snapshot
8.2. North America Thyroid Cancer Diagnostic Market
  8.2.1. U.S. Thyroid Cancer Diagnostic Market
    8.2.1.1. Type breakdown estimates & forecasts, 2017-2027
    8.2.1.2. Technique breakdown estimates & forecasts, 2017-2027
    8.2.1.3. End-Use breakdown estimates & forecasts, 2017-2027
  8.2.2. Canada Thyroid Cancer Diagnostic Market
8.3. Europe Thyroid Cancer Diagnostic Market Snapshot
  8.3.1. U.K. Thyroid Cancer Diagnostic Market
  8.3.2. Germany Thyroid Cancer Diagnostic Market
  8.3.3. France Thyroid Cancer Diagnostic Market
  8.3.4. Spain Thyroid Cancer Diagnostic Market
  8.3.5. Italy Thyroid Cancer Diagnostic Market
  8.3.6. Rest of Europe Thyroid Cancer Diagnostic Market
8.4. Asia-Pacific Thyroid Cancer Diagnostic Market Snapshot
  8.4.1. China Thyroid Cancer Diagnostic Market
  8.4.2. India Thyroid Cancer Diagnostic Market
  8.4.3. Japan Thyroid Cancer Diagnostic Market
  8.4.4. Australia Thyroid Cancer Diagnostic Market
  8.4.5. South Korea Thyroid Cancer Diagnostic Market
  8.4.6. Rest of Asia Pacific Thyroid Cancer Diagnostic Market
8.5. Latin America Thyroid Cancer Diagnostic Market Snapshot
  8.5.1. Brazil Thyroid Cancer Diagnostic Market
  8.5.2. Mexico Thyroid Cancer Diagnostic Market
8.6. Rest of The World Thyroid Cancer Diagnostic Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. F. Hoffmann-La Roche Ltd.
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Product Summary
    9.2.1.5. Recent Developments
  9.2.2. Abbott Laboratories
  9.2.3. Thermo Fisher Scientific, Inc.
  9.2.4. General Electric
  9.2.5. Siemens Healthcare GmbH
  9.2.6. Bio-Rad Laboratories, Inc.
  9.2.7. Toshiba Corporation
  9.2.8. Koninklijke Philips N.V.
  9.2.9. Agilent Technologies, Inc.

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Thyroid Cancer Diagnostic market, report scope
TABLE 2. Global Thyroid Cancer Diagnostic market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Thyroid Cancer Diagnostic market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Thyroid Cancer Diagnostic market estimates & forecasts by Technique 2017-2027 (USD Billion)
TABLE 5. Global Thyroid Cancer Diagnostic market estimates & forecasts by End-Use 2017-2027 (USD Billion)
TABLE 6. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 7. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Thyroid Cancer Diagnostic market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Thyroid Cancer Diagnostic market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. U.S. Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. U.S. Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 24. U.S. Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. Canada Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 26. Canada Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 27. Canada Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. UK Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 29. UK Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 30. UK Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. Germany Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 32. Germany Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 33. Germany Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. France Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 35. France Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 36. France Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. Spain Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 38. Spain Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 39. Spain Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Italy Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 41. Italy Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 42. Italy Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. ROE Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 44. ROE Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 45. ROE Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. China Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 47. China Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 48. China Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. India Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 50. India Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 51. India Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. Japan Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 53. Japan Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 54. Japan Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Australia Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 56. Australia Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 57. Australia Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. South Korea Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 59. South Korea Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 60. South Korea Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 61. ROPAC Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 62. ROPAC Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 63. ROPAC Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. Brazil Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 65. Brazil Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 66. Brazil Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. Mexico Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 68. Mexico Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 69. Mexico Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. ROLA Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 71. ROLA Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 72. ROLA Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 73. ROW Thyroid Cancer Diagnostic market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 74. ROW Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 75. ROW Thyroid Cancer Diagnostic market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. List of secondary sources, used in the study of global Thyroid Cancer Diagnostic market
TABLE 77. List of primary sources, used in the study of global Thyroid Cancer Diagnostic market
TABLE 78. Years considered for the study
TABLE 79. Exchange rates considered

LIST OF FIGURES

FIG 1. Global Thyroid Cancer Diagnostic market, research methodology
FIG 2. Global Thyroid Cancer Diagnostic market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Thyroid Cancer Diagnostic market, key trends 2019
FIG 5. Global Thyroid Cancer Diagnostic market, growth prospects 2020-2027
FIG 6. Global Thyroid Cancer Diagnostic market, porters 5 force Model
FIG 7. Global Thyroid Cancer Diagnostic market, pest analysis
FIG 8. Global Thyroid Cancer Diagnostic market, value chain analysis
FIG 9. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Thyroid Cancer Diagnostic market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Thyroid Cancer Diagnostic market, regional snapshot 2017 & 2027
FIG 18. North America Thyroid Cancer Diagnostic market 2017 & 2027 (USD Billion)
FIG 19. Europe Thyroid Cancer Diagnostic market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Thyroid Cancer Diagnostic market 2017 & 2027 (USD Billion)
FIG 21. Latin America Thyroid Cancer Diagnostic market 2017 & 2027 (USD Billion)
FIG 22. Global Thyroid Cancer Diagnostic market, company market share analysis (2019)

COMPANIES MENTIONED

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Thermo Fisher Scientific, Inc.
General Electric
Siemens Healthcare GmbH
Bio-Rad Laboratories, Inc.
Toshiba Corporation
Koninklijke Philips N.V.
Agilent Technologies, Inc.


More Publications